|
Research & Development (Quarter)
|
| | -4.86M | | -9.08M |
|
Selling, General & Administrative (Quarter)
|
| | -1.90M | | -3.99M |
|
Operating Expenses (Quarter)
|
| | -6.76M | | -13.07M |
|
EBIT (Quarter)
|
| | -17.22M | | -13.13M |
|
Other Non Operating Income (Quarter)
|
| | 0.10M | | -0.06M |
|
Non Operating Income (Quarter)
|
| | -0.09M | | -0.24M |
|
EBT (Quarter)
|
| | -17.22M | | -13.13M |
|
Profit After Tax (Quarter)
|
| | -16.93M | | -12.35M |
|
Income from Continuing Operations (Quarter)
|
| | -17.22M | | -13.13M |
|
Consolidated Net Income (Quarter)
|
| | -17.22M | | -13.13M |
|
Income towards Parent Company (Quarter)
|
| | -17.22M | | -13.13M |
|
Net Income towards Common Stockholders (Quarter)
|
| | -17.22M | | -13.13M |
|
EPS (Basic) (Quarter)
|
| | -0.22 | | -0.14 |
|
Shares Outstanding (Weighted Average) (Quarter)
|
53.97M | 102.26M | 78.71M | 243.72M | 92.56M |
|
EBITDA (Quarter)
|
| | -17.22M | | -13.13M |